Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vistagen Therapeutics, Inc. | 17,600 | reported | 09 Sept 2025 | tx 5+219,200 |
| AN2 Therapeutics, Inc. | 0 | reported | 19 Mar 2026 | tx 13+203,758−45,567 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 11,463 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 11,463 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 10,362 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 10,362 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 23,742 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 23,742 | — | deriv |
| 20 Feb 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 20,400 | 0.00 USD | deriv |
| 09 Sept 2025 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 17,600 | 0.00 USD | deriv |
| 28 May 2025 | PURCHASE | AN2 Therapeutics, Inc. | 8,610 | 1.18 USD | |
| 22 May 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 19,111 | 0.00 USD | deriv |
| 06 Sept 2024 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 14,100 | 0.00 USD | deriv |
| 19 Jun 2024 | GRANT_AWARD | AN2 Therapeutics, Inc. | 64,503 | 0.00 USD | deriv |
| 04 Mar 2024 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | AN2 Therapeutics, Inc. | 23,742 | 0.00 USD | deriv |
| 12 May 2022 | GRANT_AWARD | AN2 Therapeutics, Inc. | 10,362 | 0.00 USD | deriv |
| 05 May 2022 | GRANT_AWARD | AN2 Therapeutics, Inc. | 11,463 | 0.00 USD | deriv |
| 01 Mar 2022 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 21 Jul 2021 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |